Literature DB >> 24013066

Stepwise, non-adherent differentiation of human pluripotent stem cells to generate basal forebrain cholinergic neurons via hedgehog signaling.

Lucy A Crompton1, Meg L Byrne, Hannah Taylor, Talitha L Kerrigan, Gilles Bru-Mercier, Jennifer L Badger, Peter A Barbuti, Jihoon Jo, Sue J Tyler, Shelley J Allen, Tilo Kunath, Kwangwook Cho, Maeve A Caldwell.   

Abstract

Basal forebrain cholinergic neurons (bfCNs) which provide innervation to the hippocampus and cortex, are required for memory and learning, and are primarily affected in Alzheimer's Disease (AD), resulting in related cognitive decline. Therefore generation of a source of bfCNs from human pluripotent stem cells (hPSCs) is crucial for in vitro disease modeling and development of novel AD therapies. In addition, for the advancement of regenerative approaches there is a requirement for an accurate developmental model to study the neurogenesis and survival of this population. Here we demonstrate the efficient production of bfCNs, using a novel embryoid body (EB) based non-adherent differentiation (NAdD) protocol. We establish a specific basal forebrain neural stem cell (NSC) phenotype via expression of the basal forebrain transcription factors NKX2.1 and LHX8, as well as the general forebrain marker FOXG1. We present evidence that this lineage is achieved via recapitulation of embryonic events, with induction of intrinsic hedgehog signaling, through the use of a 3D non-adherent differentiation system. This is the first example of hPSC-derived basal forebrain-like NSCs, which are scalable via self-renewal in prolonged culture. Furthermore upon terminal differentiation these basal forebrain-like NSCs generate high numbers of cholinergic neurons expressing the specific markers ChAT, VACht and ISL1. These hPSC-derived bfCNs possess characteristics that are crucial in a model to study AD related cholinergic neuronal loss in the basal forebrain. Examples are expression of the therapeutic target p75(NTR), the release of acetylcholine, and demonstration of a mature, and functional electrophysiological profile. In conclusion, this work provides a renewable source of human functional bfCNs applicable for studying AD specifically in the cholinergic system, and also provides a model of the key embryonic events in human bfCN development.
© 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24013066     DOI: 10.1016/j.scr.2013.08.002

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  21 in total

Review 1.  Induced pluripotent stem cells (iPSCs) as model to study inherited defects of neurotransmission in inborn errors of metabolism.

Authors:  Sabine Jung-Klawitter; Thomas Opladen
Journal:  J Inherit Metab Dis       Date:  2018-07-06       Impact factor: 4.982

Review 2.  Generation of defined neural populations from pluripotent stem cells.

Authors:  Sarah F McComish; Maeve A Caldwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-07-05       Impact factor: 6.237

3.  Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Authors:  Sarah Logan; Thiago Arzua; Scott G Canfield; Emily R Seminary; Samantha L Sison; Allison D Ebert; Xiaowen Bai
Journal:  Compr Physiol       Date:  2019-03-14       Impact factor: 9.090

4.  Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.

Authors:  Lidia Tagliafierro; Omolara-Chinue Glenn; Madison E Zamora; Thomas G Beach; Randy L Woltjer; Michael W Lutz; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2017-04-18       Impact factor: 21.566

Review 5.  High content analysis in amyotrophic lateral sclerosis.

Authors:  Federica Rinaldi; Dario Motti; Laura Ferraiuolo; Brian K Kaspar
Journal:  Mol Cell Neurosci       Date:  2016-12-11       Impact factor: 4.314

Review 6.  Small molecule screening in human induced pluripotent stem cell-derived terminal cell types.

Authors:  Sandra J Engle; Fabien Vincent
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 7.  Up-regulation of SNCA gene expression: implications to synucleinopathies.

Authors:  L Tagliafierro; O Chiba-Falek
Journal:  Neurogenetics       Date:  2016-03-07       Impact factor: 2.660

8.  Multiplication of the SNCA locus exacerbates neuronal nuclear aging.

Authors:  Lidia Tagliafierro; Madison Elena Zamora; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

Review 9.  Striatal cholinergic interneurons in isolated generalized dystonia-rationale and perspectives for stem cell-derived cellular models.

Authors:  Philipp Capetian; Martje Gesine Pauly; Luis Manuel Azmitia; Christine Klein
Journal:  Front Cell Neurosci       Date:  2014-07-28       Impact factor: 5.505

Review 10.  Human Embryonic Stem Cells: A Model for the Study of Neural Development and Neurological Diseases.

Authors:  Piya Prajumwongs; Oratai Weeranantanapan; Thiranut Jaroonwitchawan; Parinya Noisa
Journal:  Stem Cells Int       Date:  2016-04-28       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.